Chlorpheniramine maleate and Weakness - a phase IV clinical study of FDA data
Weakness is found among people who take Chlorpheniramine maleate, especially for people who are female, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Chlorpheniramine maleate and have Weakness. It is created by eHealthMe based on reports of 3,789 people who have side effects when taking Chlorpheniramine maleate from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
3,789 people reported to have side effects when taking Chlorpheniramine maleate.
Among them, 107 people (2.82%) have Weakness.
What is Chlorpheniramine maleate?
Chlorpheniramine maleate has active ingredients of chlorpheniramine maleate. It is often used in allergies. eHealthMe is studying from 5,230 Chlorpheniramine maleate users for its effectiveness, alternative drugs and more.
What is Weakness?
Weakness is found to be associated with 5,097 drugs and 6,020 conditions by eHealthMe.
Number of Chlorpheniramine maleate and Weakness reports submitted per year:
Time on Chlorpheniramine maleate when people have Weakness *:
Gender of people who have Weakness when taking Chlorpheniramine maleate*:
Age of people who have Weakness when taking Chlorpheniramine maleate *:
Common drugs people take besides Chlorpheniramine maleate *:
Common side effects people have besides Weakness *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Chlorpheniramine maleate and have Weakness?Check whether Weakness is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Weakness and when was it recovered:
Expand to all the drugs that have ingredients of chlorpheniramine maleate:
Alternative drugs to, pros and cons of Chlorpheniramine maleate:
- Chlorpheniramine maleate (5,230 reports)
Common Chlorpheniramine maleate side effects:
Browse all side effects of Chlorpheniramine maleate:a b c d e f g h i j k l m n o p q r s t u v w x y z
Weakness treatments and more:
- Weakness (513,173 reports)
COVID vaccines that are related to Weakness:
- Weakness in Moderna COVID Vaccine
- Weakness in Pfizer BioNTech Covid Vaccine
- Weakness in Johnson and Johnson Covid Vaccine
Common drugs associated with Weakness:
All the drugs that are associated with Weakness:
- Weakness (5,097 drugs)
Common conditions associated with Weakness:
All the conditions that are associated with Weakness:
- Weakness (6,020 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on chlorpheniramine maleate (the active ingredients of Chlorpheniramine maleate) and Chlorpheniramine maleate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Propulsid and Depression Aggravated - a second ago
- Evamist and Bupropion Hydrochloride drug interaction - a second ago
- Decadron and Wound Secretion - a second ago
- Gemzar and Peripheral Occlusive Disease - 6 seconds ago
- Capecitabine and Brain Cancer Metastatic - 6 seconds ago
- Dexamethasone Acetate and Myalgia Aggravated - 8 seconds ago
- Coral and Xanax drug interaction - 11 seconds ago
- Mirena and Abortion Induced - 11 seconds ago
- Intuniv and Oxcarbazepine drug interaction - 18 seconds ago
- Xalatan and Pupil Fixed - 22 seconds ago